UncategorizedNanoscope unveils 3-year remain trial results for retinitis pigmentosa – Longevity.Technology Empower Meds / August 27, 2025
UncategorizedJupiter Neurosciences launches Nugevia website and opens pre-orders – Longevity.Technology Empower Meds / August 27, 2025
UncategorizedSerina Therapeutics gets FDA support for SER-252 registrational trial design – Longevity.Technology Empower Meds / August 27, 2025
UncategorizedHCW Biologics unveils second-generation immune checkpoint inhibitor – Longevity.Technology Empower Meds / August 27, 2025
UncategorizedHuman Longevity partners with Alamar Biosciences to enhance longevity research – Longevity.Technology Empower Meds / August 27, 2025
UncategorizedHuman Longevity taps precision proteomics for early detection Empower Meds / August 27, 2025
UncategorizedProtagenic Therapeutics advances PT00114 into multiple-dose phase 1 – Longevity.Technology Empower Meds / August 26, 2025
UncategorizedLighthouse pharmaceuticals wins $49.2 million NIA grant for Alzheimer’s trial – Longevity.Technology Empower Meds / August 26, 2025
